Trial Profile
A bioequivalency study of novel levetiracetam extended release 1500 mg tablets under fasing/non fasting swithcover conditions in heathy subjects.
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 05 May 2017
Price :
$35
*
At a glance
- Drugs Levetiracetam (Primary)
- Indications Myoclonic epilepsies; Partial epilepsies; Tonic-clonic epilepsy
- Focus Pharmacokinetics
- 05 May 2017 New trial record
- 28 Apr 2017 Results assessing bioequivalence using patient data from this and other two trials (see CTPs 284435 and 284433), presented at the 69th Annual Meeting of the American Academy of Neurology